Alnylam Pharmace. buy Biotechhunter
Start price
05.05.20
/
50%
€132.36
Target price
13.05.20
-
Performance (%)
-1.84%
End price
13.05.20
€129.92
Summary
This prediction ended on 13.05.20 with a price of €129.92. With a performance of -1.84%, the BUY prediction by Biotechhunter finished with a loss. Biotechhunter has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 3.192% | 3.192% | -49.479% | 14.628% |
| iShares Core DAX® | 0,44 % | 5,90 % | 8,05 % | 65,58 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % | 28,47 % | 90,18 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % | 47,57 % | 84,99 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 23,20 % | 70,76 % |
Comments by Biotechhunter for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.